Norrin Protects Retinal Ganglion Cells from Death
Author Information
Author(s): Lin Song, Cheng Mei, Dailey Wendelin, Drenser Kimberly, Chintala Shravan
Primary Institution: Eye Research Institute of Oakland University
Hypothesis
Norrin attenuates protease-mediated death of transformed retinal ganglion cells by activating the Wnt/beta-catenin signaling pathway.
Conclusion
Norrin helps protect retinal ganglion cells from death caused by certain proteases by activating a specific signaling pathway and regulating a receptor's phosphorylation.
Supporting Evidence
- Norrin treatment increased cell survival in the presence of harmful proteases.
- Norrin activated the Wnt pathway, which is important for cell survival.
- Norrin restored phosphorylation of LRP-1, a receptor involved in cell death.
Takeaway
Norrin is like a superhero for certain eye cells, helping them stay alive even when bad things try to hurt them.
Methodology
Transformed retinal ganglion cells were treated with staurosporine and varying doses of norrin, and cell viability was assessed using MTT assays.
Limitations
The study used transformed RGC-5 cells, which may not fully represent primary retinal ganglion cells.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website